Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose-response Relationship”

232 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 232 results

Early research (Phase 1)UnknownNCT00002449
What this trial is testing

Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy

Who this might be right for
HIV Infections
Chiron Corporation 212
Not applicableStudy completedNCT00000718
What this trial is testing

A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 112
Early research (Phase 1)Study completedNCT00004579
What this trial is testing

See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection

Who this might be right for
HIV InfectionsHIV Seronegativity
Walter Reed Army Institute of Research (WRAIR)
Not applicableUnknownNCT00905203
What this trial is testing

Effects of Different Exercise Training Dose on Exercise Performance and Noninvasively Estimated Muscle Oxygen Extraction in Diabetic Postmenopausal Women

Who this might be right for
Postmenopausal Diabetes
National Taiwan University Hospital 45
Testing effectiveness (Phase 2)Study completedNCT00942344
What this trial is testing

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension

Who this might be right for
Hypertension
Hanmi Pharmaceutical Company Limited 320
Early research (Phase 1)Study completedNCT00001133
What this trial is testing

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableStudy completedNCT02931058
What this trial is testing

Quadriceps Exercise Before Total Knee Arthroplasty (The QUADX-1 Trial)

Who this might be right for
Osteoarthritis, Knee
Hvidovre University Hospital 140
Not applicableLooking for participantsNCT06880653
What this trial is testing

Dose Response of Exercise for Arthritis Management

Who this might be right for
ArthritisRheumatoid Arthritis (RA)Gout+3 more
University of South Carolina 285
Testing effectiveness (Phase 2)Study completedNCT01426386
What this trial is testing

A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment

Who this might be right for
Infertility
Ferring Pharmaceuticals 265
Not applicableStudy completedNCT02550132
What this trial is testing

The Role of the Rate of Force Application in Responses to Spinal Manipulation Therapy

Who this might be right for
Spinal Manipulation
Université du Québec à Trois-Rivières 25
Testing effectiveness (Phase 2)Study completedNCT00459004
What this trial is testing

Japanese Dose-Response Study of Rimonabant in Obese Patients

Who this might be right for
Obesity
Sanofi 527
Not applicableWithdrawnNCT02157545
What this trial is testing

The Dose-Response Relationship of Rocuronium in Patients Taking Pyridostigmine

Who this might be right for
Muscle Relaxants
Shashi Bhatt, MD
Large-scale testing (Phase 3)Study completedNCT00002441
What this trial is testing

Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection

Who this might be right for
HIV InfectionsHIV Seronegativity
VaxGen 5,000
Early research (Phase 1)Study completedNCT00027261
What this trial is testing

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 110
Testing effectiveness (Phase 2)Study completedNCT00460239
What this trial is testing

Buprenorphine's Dose Response Curve

Who this might be right for
Opioid-related Disorders
Johns Hopkins University 12
Testing effectiveness (Phase 2)Study completedNCT00256919
What this trial is testing

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 51
Post-approval studies (Phase 4)UnknownNCT03517319
What this trial is testing

Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity

Who this might be right for
Spasticity as Sequela of Stroke
Seoul National University Hospital 78
Early research (Phase 1)Study completedNCT00006207
What this trial is testing

Safety and Tolerability of the Vaginal Gel PRO 2000/5

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Study completedNCT01863186
What this trial is testing

Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal

Who this might be right for
Opioid DependenceAcute Opioid Withdrawal Syndrome
USWM, LLC (dba US WorldMeds) 603
Testing effectiveness (Phase 2)Study completedNCT00000825
What this trial is testing

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Next Page